GlassScriptPhysician profile
Amy Lake
NPI 1962966341
$2,216.81
in general payments reported to CMS, 2019-2025
20 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.09 · 2022: $725 · 2023: $693 · 2024: $360 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $404.11 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $372.34 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $310.50 | 2022-2025 | |
| Exeltis, USA INC. | $218.04 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $182.54 | 2023-2025 | Veozah |
| Biogen, INC. | $176.15 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $89.05 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $88.89 | 2023 | Myfembree |
| Coopersurgical, INC. | $74.85 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $68.36 | 2023-2025 | Aptima, Novasure, Acessa Provu System |
| Axsome Therapeutics, INC. | $43.76 | 2024-2025 | Auvelity |
| Myovant Sciences INC. | $31.72 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.77 | 2023 | Seglentis |
| Scynexis, INC. | $24.57 | 2022 | |
| Dexcom, INC. | $24.26 | 2025 | Dexcom G6 Transmitter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $23.02 | 2022 | |
| Avanos Medical | $16.43 | 2023 | On-Q* Pump and Accessories |
| Kerecis Limited | $14.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $12.64 | 2022 | |
| Therapeuticsmd, INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.